Key References Burlina S, Dalfra MG, Caprino R, Lapolla A
How people are using GLP-1s People with type 2 diabetes are using GLP-1 receptor agonists to improve glycemic control, reduce reliance on insulin/other drugs, and reduce risk of diabetes-related complications
Dose can be increased in 2.5 mg increments every four weeks to a maximum of 15 mg weekly
Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease
For more information on Ro's Body Membership and full suite of GLP-1 options, visit Ro.co/weightloss About Ro Ro is a direct-to-patient healthcare company with a mission of helping patients achieve their health goals by delivering the easiest, most effective care possible
Food companies employ scientists who specialize in addiction, ensuring their products are as irresistible as possible